Litcius/Paper detail

Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

Kévin Chevalier, Rakiba Belkhir, Raphaèle Séror, Xavier Mariette, Gaëtane Nocturne

2020Annals of the Rheumatic Diseases20 citationsDOI

Topics & Concepts

BelimumabB-cell activating factorRituximabMedicineImmunologyCD20VasculitisMonoclonal antibodySystemic vasculitisRefractory (planetary science)LymphomaMonoclonalB cellChronic lymphocytic leukemiaAntibodyInternal medicineLeukemiaDiseaseBiologyAstrobiologySalivary Gland Disorders and FunctionsSystemic Lupus Erythematosus ResearchGalectins and Cancer Biology
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone | Litcius